Polaryx Therapeutics, Inc. Net Income increased by 49.6% to -$2.54M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals improved profitability and potential for higher dividends or reinvestment, while a decrease may indicate rising costs or slowing sales.
Net income represents the total profit of the company after all operating expenses, interest, taxes, and preferred stock...
Peer companies in the consumer electronics and software sectors typically trade on multiples of this figure, though it can be impacted by one-time tax events.
net_income_cf| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | -$5.05M | -$2.54M |
| QoQ Change | — | +49.6% |
| YoY Change | — | +49.6% |
| Segment | Q1 '25 | Q1 '26 |
|---|---|---|
| Lysosomal Storage Disorders | -$5.05M | -$2.54M |
| Total | -$5.05M | -$2.54M |